Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지
DOI QR코드

DOI QR Code

A case study on benefit coverage of complementary medicine in public health insurance by the referendum in Switzerland

스위스에서의 국민투표에 의한 보완의학 건강보험 급여화 사례 연구

  • Kim, Dongsu (Policy & Standards Planning Team, KM Standards Centers, Korea Institute of Oriental Medicine) ;
  • Lim, Byungmook (Policy & Standards Planning Team, KM Standards Centers, Korea Institute of Oriental Medicine) ;
  • Park, Inhyo (Research Institute for Korean Medicine, Pusan National University) ;
  • Lee, Yoon Jae (Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation)
  • 김동수 (한국한의학연구원 정책표준기획팀) ;
  • 임병묵 (한국한의학연구원 정책표준기획팀) ;
  • 박인효 (부산대학교 한의과학연구소) ;
  • 이윤재 (자생의료재단 척추관절연구소)
  • Received : 2017.11.18
  • Accepted : 2017.12.16
  • Published : 2017.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background : Efforts towards increasing insurance coverage for traditional Korean medicine (TKM) are being continued. However, various difficulties are faced in generating evidence for TKM due to limited financial support and the low quality of research methodology. Objectives : The objectives of this study were to review the Swiss evaluation program for complementary and alternative medicine (CAM) and assess the expansion in public health insurance coverage of complementary medicine as approved by referendum in Switzerland. Methods : The regulations of CAM in the European Union were assessed. Research articles, reports, government publications and websites which deal with the 'Programm Evaluation $Komplement{\ddot{a}}rmedizin$ (PEK)' and the referendum in Switzerland were searched for and analyzed. Results : The PEK was conducted from 1998 to 2005. The PEK evaluated the efficacy, utilization and cost-effectiveness of anthroposophical medicine, homeopathy, neural therapy, phytotherapy and traditional Chinese medicine. However, clear conclusions could not be drawn from the evaluation according to the PEK Report. Later, a referendum was implemented in which 5 therapies would be added to the Switzerland Constitution with the support of the public. The coverage of CAM was approved by Swiss a plebiscite with an approval rate of 67.0%. Conclusions : The reason for the successful referendum is suggested to be public support and the solidarity with CAM experts and politicians. It may be surmised that recognition of the political efforts and scientific aspects required to expand insurance coverage of TKM, and towards obtaining public support, is necessary.

Keywords

References

  1. U Brugger, B Horisberger, A Ruckstuhl, R Plessow, K Eichler, A Gratwohl. Health technology assessment in Switzerland: a descriptive analysis of "Coverage with Evidence Development" decisions from 1996 to 2013. BMJ Open 2015;5:1-10
  2. Korea Institute for Health and Social Affairs. Plan about appropriate coverage of health insurance. 2007.
  3. YJ Lee & JY Kim. Status of New Health Technology in Korean Medicine Field Since 2007. J Korean Med 2017;38(1):21-33 https://doi.org/10.13048/jkm.17003
  4. Ministry of Health & Welfare.. 3rd Comprehensive development plan of Korean medicine 2016-2020. 2016.
  5. MY You. Use of economic evaluation of new drugs and change of drug price system. J. Kor. Soc. Health-Syst. Pharm 2014:31(6):1044-1053
  6. Publication Committe on Year Book of Traditional Korean Medicine. 2015 Year Book of Traditional Korean Medicine. Korea Institute of Oriental Medicine, The Association of Korean Medicine, National Development Institute of Korean Medicine, Pusan National University School of Korean Medicine.
  7. CM Witt, L Schutzler. The gap between results from sham-controlled trials and trials using other controls in acupuncture research-the influence of context. Complement Ther Med. 2013;21(2):112-4 https://doi.org/10.1016/j.ctim.2012.12.005
  8. N Nissen, S Schunder-Tatzber, W Weidenhammer, H Johannessen. What attitudes and needs do citizens in Europe have in relation to complementary and alternative medicine? Complementary Medicine Research. 2012;19(Suppl. 2):9-17. https://doi.org/10.1159/000342710
  9. S Eardley, FL Bishop, F Cardini, K Santos-Rey, MC Jong, S Ursoniu, S Dragan, G Hegyi, B Uehleke, J Vas, O Jupaneant, MC Citro, V Fonnebo, SA Quandt, G Lewith. CAM use in Europe - The patients' perspective. Part II: A pilot feasibility study of a questionnaire to determine EU wide CAM use. 2012
  10. The Commenwealth Fund, International Health Care System Profiles. http://international.commonwealthfund.org/countries/switzerland/
  11. V Fonnebo. S Wiesener, T Falkenberg, G Hegyi, J Hok, P R Sarsina, CAMbrella Work Package2-Legal status and regulation of CAM in Europe. The 7th Framework Programme of European Union Commision. 2012.
  12. European Observatory. Health Systems in Transition-Switzerland. 2015.
  13. Federal Office of Public Health. Taking Health to heart. 2015
  14. MH Lim. Trends and Future Tasks of the Switzerland Health Insurance Reform. The Korean Journal of Health Economics and Policy 2012;18(4):85-108
  15. Swiss Health Insurance Law. Bundesgesetz uber die Krankenversicherung(KVG). https://www.admin.ch/opc/de/classified-compilation/19940073/index.html
  16. HP Studer, A Busato. Development of Costs for Complementary Medicine after Provisional Inclusion into the Swiss Basic Health Insurance. Forsch Komplementmed 2011;18:15-23 https://doi.org/10.1159/000323735
  17. D Melchart, F Mitscherlich, M Amiet, R Eichenberger, P Koch. Programm Evaluation Komplementarmedizin(PEK). Bundesamt fur Gesundheit. 2005.
  18. L Rist, H Schwabl. Complementary medicine in the political process. Translated with permission of S. Karger Publisher, Freiburg. 2009.
  19. H Walach. The Swiss program for the evaluation of complementary medicine(PEK). The journal of alternative and complementary medicine 2006;12(3):231-232 https://doi.org/10.1089/acm.2006.12.231
  20. H Walach, K Linde, R Eichenberger, H Stalder, F B Kristensen, J Kleijnen. Summary consensus statement of the review board of the Swiss complementary medicine evaluation programme, (programm evaluation komplementarmedizin, PEK) regarding the PEK process and products. Homeopathy 2006;95:28-30 https://doi.org/10.1016/j.homp.2005.11.012
  21. Swiss federal referendum of 17.5.2009 https://www.admin.ch/ch/d/pore/va/20090517/index.html
  22. Swiss Federal Office of Public Health https://www.bag.admin.ch/bag/de/home/themen/strategien-politik/nationale-gesundheitspolitik/stand-umsetzung-des-neuen-verfassungsartikels-zur-komplementaermedizin.html
  23. The National Research Center in Complementary and Alternative Medicine. CAM Regulation http://nafkam-camregulation.uit.no/country/switzerland/
  24. Swiss association of complementary medicine (Dachverband Komplementarmedizin) http://www.echamp.eu/news-and-events/news/complementary-medicine-in-switzerland-now-a-mandatory-health-insurance-service
  25. Federal Office of Public Health. The compulsory health insurance in a nutshell. 2015.
  26. Swiss Health Insurance Act. Verordnung uber die Krankenversicherung(KVV). https://www.admin.ch/opc/de/classified-compilation/19950219/
  27. "Complementary medicine in switzerland now a mandatory health insurance service" - Dachverband Komplemenrarymedizin. 2017.7.16.
  28. N Nissen, H Johannessen, SS Tatzber, A Lazarus, W Weidenhammer. CAMbrella Work Package 3-Citizens' needs and attitudes towards CAM. The 7th Framework Programme of European Union Commision. 2012.
  29. P Portwich. The Swiss social insurance system: social security and grass-root democracy. International social security review 2011;64(1):95-110 https://doi.org/10.1111/j.1468-246X.2010.01386.x
  30. Swiss federal referendum of 05.06.2016 Template No. 601 Overview https://www.admin.ch/ch/d/pore/va/20160605/det601.html
  31. Swiss federal referendum of 29.11.2009 https://www.admin.ch/ch/d/pore/va/20091129/index.html
  32. FH Fischer, G Lewith, CM Witt, K Linde, K Ammon, F Cardini, T Falkenberg, V Fonnebo, H Johannessen, Bettina Reiter, B Uehleke, W Weidenhammer and B Brinkhaus. High prevalence but limited evidence in complementary and alternative medicine : guidelines for future research. BMC Complementary and Alternative Medicine 2014;14:46-54 https://doi.org/10.1186/1472-6882-14-46
  33. D Kim, SH Kwon, SH Chung, BR Ahn & B Lim. The Health Insurance system and the Quality Improvement Policies for Chinese Medicine in Taiwan. Journal of Society of Preventive Korean Medicine 2016;20(2):27-38
  34. N Nissen, W Weidenhammer, S Schunder-Tatzber, H Johannessen. Public health ethics for complementary and alternative medicine. European Journal of Integrative Medicine 2013;5:62-67 https://doi.org/10.1016/j.eujim.2012.11.003